Clinical trial
Comparative Study Between the Use of Corifollitropin Alfa and Daily Recombinant FSH in the Controlled Ovarian Stimulation of Poor Responders
NCT02254928 is registered in ClinicalTrials.gov with Vida Recoletas Sevilla as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparative Study Between the Use of Corifollitropin Alfa and Daily Recombinant FSH in the Controlled Ovarian Stimulation of Poor Responders
- Lead sponsor
- Vida Recoletas Sevilla
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- September 30, 2014
- Completion date
- November 30, 2015
- Enrollment
- 26 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.